AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Cryo-Cell International Inc.
XASE · usd
SIC 8090 · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
FIGI BBG001S6Z7X3
4.46▼ 0.04 (-0.78%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
4.49
Day's Range
4.29 – 4.69
52-Week Range
2.67 – 4.90
Volume
1,437
Avg Volume
13.8K
Share Statistics
Shares Outstanding
Employees
76
Exchange
XASE
Listed
—
Share count as of October 8, 2026

Cryo-Cell International Inc. (CCEL) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Cryo-Cell International Inc. (CCEL)
What is Cryo-Cell International Inc.'s Market Cap?
Cryo-Cell International Inc.'s Market Cap is $35.9M, based on as-reported figures from SEC (XBRL) filings.
What is Cryo-Cell International Inc.'s Enterprise Value?
Cryo-Cell International Inc.'s Enterprise Value is $39.9M, based on as-reported figures from SEC (XBRL) filings.
What is Cryo-Cell International Inc.'s Price / Sales?
Cryo-Cell International Inc.'s Price / Sales is 1.2×, based on as-reported figures from SEC (XBRL) filings.
What is Cryo-Cell International Inc.'s EV / Revenue?
Cryo-Cell International Inc.'s EV / Revenue is 1.3×, based on as-reported figures from SEC (XBRL) filings.
What is Cryo-Cell International Inc.'s EV / EBITDA?
Cryo-Cell International Inc.'s EV / EBITDA is 34.4×, based on as-reported figures from SEC (XBRL) filings.
What is Cryo-Cell International Inc.'s Revenue (TTM)?
Cryo-Cell International Inc.'s Revenue (TTM) is $31.1M, based on as-reported figures from SEC (XBRL) filings.
What is Cryo-Cell International Inc.'s Net Income (TTM)?
Cryo-Cell International Inc.'s Net Income (TTM) is -$1.9M, based on as-reported figures from SEC (XBRL) filings.
What is Cryo-Cell International Inc.'s EBITDA?
Cryo-Cell International Inc.'s EBITDA is $1.2M, based on as-reported figures from SEC (XBRL) filings.
What is Cryo-Cell International Inc.'s Diluted EPS (TTM)?
Cryo-Cell International Inc.'s Diluted EPS (TTM) is -0.24, based on as-reported figures from SEC (XBRL) filings.
What is Cryo-Cell International Inc.'s EBITDA Margin?
Cryo-Cell International Inc.'s EBITDA Margin is 3.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CCELAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemAug 31, 2026May 31, 2026Feb 28, 2026Nov 30, 2025Aug 31, 2025May 31, 2025Feb 28, 2025Nov 30, 2024Aug 31, 2024May 31, 2024Feb 29, 2024Nov 30, 2023Aug 31, 2023May 31, 2023Feb 28, 2023Nov 30, 2022
Revenue
YoY growth-0.0%-1.9%-3.6%-2.3%
Costs and Expenses:
Cost of sales
Selling, general and administrative expenses
Impairment of investment————
Research, development and related engineering
Depreciation and amortization
Total costs and expenses
% of revenue72.0%84.6%90.0%150.6%
Operating Income
% of revenue28.0%15.4%10.0%-50.6%
Other Income (Expense):
Gains (losses) gains on marketable securities
Gain on interest rate swap————
Other income
Interest expense
Total other (expense) income
Income before income tax expense
Income tax expense
Net income
% of revenue16.2%7.1%0.6%-48.7%
Net income per common share - basic
Net income per common share - diluted—